Lansoprazol Viatris (Lansoprazole)

Lansoprazole works by irreversibly blocking the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition stops the final step of acid production, leading to a sustained reduction in gastric acidity and allowing acid‑related lesions to heal.

The appropriate dose of Lansoprazol Viatris is determined by a qualified prescriber based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the dosing instructions provided by their healthcare professional and the product label.

Lansoprazole is classified as a pregnancy category C medication in many regions, meaning it should only be used when the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding; the drug does pass into breast milk in small amounts, so a prescriber should evaluate the risk‑benefit ratio.

To order Lansoprazol Viatris, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lansoprazole belongs to the same class as omeprazole, esomeprazole and pantoprazole. All share a similar mechanism of inhibiting the gastric proton pump, but pharmacokinetic differences exist; for example, lansoprazole has a slightly faster onset of action and may be preferred in patients who experience breakthrough symptoms on other PPIs.

Lansoprazol Viatris tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture, direct sunlight and excessive heat to maintain potency throughout its shelf life.

The medication is taken orally, usually as a whole tablet swallowed with a glass of water. For most indications it is recommended to take the dose before a meal, typically in the morning, unless the prescriber advises a different schedule.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, low magnesium levels (hypomagnesemia) with long‑term use, liver enzyme elevations indicating possible hepatic injury, and rare skin reactions like Stevens‑Johnson syndrome.

Patients with known hypersensitivity to lansoprazole or any component of the formulation should avoid the product. Caution is also advised for individuals with severe liver disease, those taking certain interacting medications without medical supervision, and patients for whom alternative acid‑reducing therapies are more appropriate.